خرید گزارش Iran Pharmaceuticals & Healthcare Report
برای دانلود گزارش Iran Pharmaceuticals & Healthcare Report سال 2018 از bmiresearch.com با ما مکاتبه کنید. ریپورت صنعت داروسازی و بهداشت در ایران در ارشیو گیگاپیپر موجود است.
دانلود گزارش BMI داروسازی Pharmaceuticals & Healthcare
Iran Pharmaceuticals & Healthcare Report
Providing expert analysis, independent forecasts and competitive intelligence on the pharmaceuticals and healthcare industry.
Report includes: BMI Industry View, Industry SWOT Analysis, Industry Forecasts, BMI’s Pharmaceuticals and Healthcare Risk Reward Index, Market Summary, Economic Forecasts, Company Profiles and Competitive Landscape.
Why you should buy this report
Benefit from the latest market opportunities
Understand the threats to your operations and investments and protect your company against future risks
Gain insight on emerging trends that could support, strengthen or disrupt your activities in the market
Get a full view of the competitive landscape to assess your market position
دانلود گزارش صنعت داروسازی و بهداشت در ایران
ارائه تحلیل کارشناسانه، پیش بینی مستقل و اطلاعات رقابتی در زمینه داروسازی و صنایع بهداشتی.
گزارش شامل: نمایش صنعت BMI، تجزیه و تحلیل SWOT در صنعت، پیش بینی های صنعت، داروهای BMI و شاخص پاداش های بهداشت و درمان، خلاصه بازار، پیش بینی های اقتصادی، مشخصات شرکت ها و چشم انداز رقابتی.
چرا باید این گزارش را بخرید
از آخرین فرصت های بازار بهره مند شوید
درک تهدیدات عملیات و سرمایه گذاری های خود و محافظت از شرکت خود در برابر خطرات آینده
به دست آوردن بینش در مورد روند در حال ظهور است که می تواند حمایت، تقویت و یا اختلال فعالیت های خود را در بازار است
برای ارزیابی وضعیت بازار خود، یک دید کلی از چشم انداز رقابتی دریافت کنید.
اطلاعات بیشتر این گزارش BMI در سایت Business Monitor از ادرس https://store.bmiresearch.com/iran-pharmaceuticals-healthcare-report.html
دانلود رایگان گزارش Pharmaceuticals & Healthcare Report در ایران
جهت اطمینان از اورجینال بودن گزارش و کیفیت خوب فایل PDF گزارش، چند صفحه از ان بصورت رایگان اورده شده است.
Key Benefits
Benchmark BMI’s pharmaceutical and healthcare market forecasts for Iran, to test other views – a key input for successful budgeting and strategic business planning in the Iranian pharmaceutical and healthcare market.
Target business opportunities and risks in the Iranian pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in Iran.
Assess the activities, strategy and market position of your competitors using our company profiles (including SWOTs, KPIs and latest activity) and competitive landscape tables.
Coverage
BMI Industry View
An at-a-glance perspective on the latest regulatory developments, key forecast indicators and major corporate developments, covering the prescription, OTC and generics markets. The pharmaceuticals and healthcare SWOT outlines strategic factors that affect the basic assumptions underpinning BMI’s forecast analysis, and taken together with BMI’s political, economic and business environment SWOTs, it gives a complete overview of market climate.
BMI Industry Forecast Scenario
Industry forecasts to end-2019 for all key indicators, supported by explicit assumptions, plus analysis of key downside risks to the main forecasts:
Healthcare: Total healthcare expenditure (USDbn), healthcare expenditure (% of GDP), healthcare expenditure per capita (USD), hospital beds, doctors, and birth & mortality rates (all per ‘000 population).
Pharmaceutical Market: Drug expenditure in USDbn, % of GDP and per capita (USD).
Patented Drug Market: Prescription drug sales (USDbn & % of total sales).
Generic Drug Market: Generic product sales (USDbn), generic sales (% of total sales).
OTC Drug Market: OTC sales (USDbn & % of total sales).
Macroeconomic Forecasts: Nominal and real GDP, % real GDP growth, % private consumption growth, % industrial output growth, % consumer price index, % GDP price deflator, exports, imports, trade balance, current account balance, foreign direct investment, exchange rate against USD, government expenditure and external debt.
BMI’s Pharmaceuticals and Healthcare Risk Reward Index
BMI’s Risk Reward Index provides investors (both national and multinational) looking for opportunities in the region with a clear country-comparative assessment of the market’s risks and potential rewards. Each of the country markets are scored using a sophisticated model that includes more than 40 industry, economic and demographic data points to provide indices of highest to lowest appeal to investors, with each position explained.